4/A: Teleflex CFO Thomas E. Powell Amends Filing to Correct Stock Unit Award
SEC Filing (Form 4/A)
Thomas E. Powell, Executive Vice President & CFO of Teleflex Inc., amended a previous filing to correct the number of shares underlying a Restricted Stock Unit Award.
Summary
- Thomas E. Powell, the Executive Vice President & CFO of Teleflex Inc., filed an amendment to a previous Form 4 filing.
- The amendment corrects the number of shares underlying Mr. Powell's Restricted Stock Unit Award from 2373 to 2398.
- The original transaction date was February 27, 2024.
- Powell was granted 2,398 shares of common stock as a Restricted Stock Unit Award under the Teleflex Incorporated 2023 Stock Incentive Plan.
- These shares vest 100% on the third anniversary of the grant date.
- Powell also acquired 16,821 stock options with an exercise price of $226.04, exercisable in three equal installments on 2/27/2025, 2/27/2026, and 2/27/2027, expiring on 02/27/2034.
- Following the reported transactions, Powell beneficially owns 17,450 shares of common stock directly and additional shares indirectly through a 401(k) trustee.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing related to executive compensation. The correction of the stock unit award is a neutral event, and the overall sentiment is slightly positive due to the alignment of executive interests with shareholders through equity-based compensation.
Positives
- The grant of restricted stock units and stock options aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Comparison to Industry Standards
- Executive compensation packages including stock options and restricted stock units are common in publicly traded companies like Teleflex to incentivize performance and align management interests with shareholders.
- Vesting schedules, such as the three-year vesting period for the restricted stock units and the staggered vesting for the stock options, are typical in the industry to promote long-term commitment.
- Companies like Medtronic, Boston Scientific, and Abbott Laboratories also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- Shareholders benefit from transparency regarding executive compensation and alignment of interests.
- Employees may be indirectly impacted by the incentive structure for executives, which can influence company performance.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of the original transaction and grant of Restricted Stock Unit Award and Stock Options. |
| 02/28/2024 | Date of original filing. |
| 02/27/2025 | First vesting date for one-third of the stock options. |
| 02/27/2026 | Second vesting date for one-third of the stock options. |
| 02/27/2027 | Final vesting date for one-third of the stock options and vesting date for the Restricted Stock Units. |
| 02/27/2034 | Expiration date of the stock options. |
| 06/20/2024 | Date of the amended filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.